Literature DB >> 12093643

The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes : the atherosclerosis risk in communities study.

Ronald Klein1, A Richey Sharrett, Barbara E K Klein, Scot E Moss, Aaron R Folsom, Tien Y Wong, Frederick L Brancati, Larry D Hubbard, David Couper.   

Abstract

PURPOSE: The aim of this report is to describe the prevalence of retinopathy and its associations with atherosclerosis and vascular risk factors in people with diabetes.
DESIGN: Cross-sectional study. PARTICIPANTS: Persons with diabetes, having gradable fundus photographs, from a biracial population-based cohort of adults (ages 51-72 years), and living in four United States communities (Forsyth County, North Carolina; the city of Jackson, Mississippi; suburbs of Minneapolis, Minnesota; and Washington County, Maryland) were studied from 1993 to 1995.
METHODS: Lesions typical of diabetic retinopathy were detected by grading a 45 degrees color fundus photograph of one eye of each participant, using a modification of the Airlie House classification system. MAIN OUTCOME MEASURE: Severity of diabetic retinopathy (none, minimal nonproliferative, moderate nonproliferative, severe nonproliferative, and proliferative) and macular edema.
RESULTS: Retinopathy was detected in 328/1600 (20.5%) of those with diabetes; 114/1724 (6.6%) had hard exudate, 28/1600 (1.8%) had proliferative diabetic retinopathy, and 27/1662 (1.6%) had macular edema. The prevalence of diabetic retinopathy was higher in blacks (27.7%) compared with whites (16.7%). Controlling for duration of diabetes, serum glucose, systolic blood pressure, and type of diabetes medications taken, severity of retinopathy was associated with carotid artery intima-media wall thickness (odds ratio [OR]/0.1-mm thickness 1.09; 95% confidence interval [CI], 1.01, 1.17; P = 0.01), serum albumin (OR/0.1 g/dl 0.94; 95% CI, 0.88, 0.99; P = 0.02), but not race (OR blacks versus whites,1.24; 95% CI, 0.88, 1.75; P = 0.21). Severity of diabetic retinopathy was not associated with coronary artery disease or stroke history or any of the plasma lipids studied. Controlling for age, gender, duration of diabetes, serum glucose, and type of diabetes medications taken, the presence of retinal hard exudates was associated with plasma low-density lipoprotein cholesterol (OR/10 mg/dl 1.18; 95% CI, 1.09, 1.29; P < 0.001), and plasma Lp(a) (OR/10 mg/dl 1.02; 95% CI, 1.00, 1.05; P = 0.04) but not race or blood pressure.
CONCLUSIONS: These data suggest that plasma lipids are associated with the presence of hard exudate and that carotid artery intima-media wall thickness is associated with retinopathy, but other manifestations of atherosclerosis and most of its risk factors are not associated with severity of diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12093643     DOI: 10.1016/s0161-6420(02)01074-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  84 in total

Review 1.  Screening for diabetic retinopathy and diabetic macular edema in the United Kingdom.

Authors:  Tunde Peto; Christine Tadros
Journal:  Curr Diab Rep       Date:  2012-08       Impact factor: 4.810

2.  Racial Differences in and Prognostic Value of Biomarkers of Hyperglycemia.

Authors:  Christina M Parrinello; A Richey Sharrett; Nisa M Maruthur; Richard M Bergenstal; Morgan E Grams; Josef Coresh; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2015-12-17       Impact factor: 19.112

Review 3.  The role of genetics in susceptibility to diabetic retinopathy.

Authors:  Gerald Liew; Ronald Klein; Tien Y Wong
Journal:  Int Ophthalmol Clin       Date:  2009

4.  Association of serum lipid levels with retinal hard exudate area in African Americans with type 2 diabetes.

Authors:  Evangelia Papavasileiou; Samaneh Davoudi; Ramak Roohipoor; Heeyoon Cho; Shreyas Kudrimoti; Heather Hancock; James G Wilson; Christopher Andreoli; Deeba Husain; Maurice James; Alan Penman; Ching J Chen; Lucia Sobrin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-09-15       Impact factor: 3.117

Review 5.  Challenges in elucidating the genetics of diabetic retinopathy.

Authors:  Jane Z Kuo; Tien Y Wong; Jerome I Rotter
Journal:  JAMA Ophthalmol       Date:  2014-01       Impact factor: 7.389

6.  Tyrosine nitration of prostacyclin synthase is associated with enhanced retinal cell apoptosis in diabetes.

Authors:  Ming-Hui Zou; Hongliang Li; Chaoyong He; Mingkai Lin; Timothy J Lyons; Zhonglin Xie
Journal:  Am J Pathol       Date:  2011-10-18       Impact factor: 4.307

7.  Effect of focal laser photocoagulation in eyes with mild to moderate non-proliferative diabetic retinopathy.

Authors:  Seong Hun Jeong; Jung Il Han; Sung Won Cho; Dong Won Lee; Chul Gu Kim; Tae Gon Lee; Jong Woo Kim
Journal:  Int J Ophthalmol       Date:  2016-10-18       Impact factor: 1.779

Review 8.  Blood pressure control for diabetic retinopathy.

Authors:  Diana V Do; Xue Wang; Satyanarayana S Vedula; Michael Marrone; Gina Sleilati; Barbara S Hawkins; Robert N Frank
Journal:  Cochrane Database Syst Rev       Date:  2015-01-31

9.  Risk Factors for Proliferative Diabetic Retinopathy in African Americans with Type 2 Diabetes.

Authors:  Alan Penman; Heather Hancock; Evangelia Papavasileiou; Maurice James; Omolola Idowu; Daniel M Riche; Marlene Fernandez; Stacey Brauner; Sataria O Smith; Suzanne Hoadley; Cole Richardson; Vanessa Vazquez; Cheryl Chi; Christopher Andreoli; Deeba Husain; Ching J Chen; Lucia Sobrin
Journal:  Ophthalmic Epidemiol       Date:  2016-03-07       Impact factor: 1.648

10.  Diagonal ear lobe crease in diabetic south Indian population: is it associated with Diabetic Retinopathy?. Sankara Nethralaya Diabetic Retinopathy Epidemiology And Molecular-genetics Study (SN-DREAMS, Report no. 3).

Authors:  Rajiv Raman; Padmaja Kumari Rani; Vaitheeswaran Kulothungan; Tarun Sharma
Journal:  BMC Ophthalmol       Date:  2009-09-29       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.